PMGC HOLDINGS INC. Travel and Entertainment Expense
PMGC HOLDINGS INC. (ELAB) reported Travel and Entertainment Expense of $63.44 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:TravelAndEntertainmentExpense · last filed 2026-08-14
- PMGC HOLDINGS INC. travel and entertainment expense for the quarter ending 2026-06-30 was $63.44K, a 291.80% increase year-over-year.
- PMGC HOLDINGS INC. travel and entertainment expense for the quarter ending 2026-03-31 was $108.34K, a 176.24% increase year-over-year.
- PMGC HOLDINGS INC. travel and entertainment expense for the quarter ending 2025-12-31 was $40.69K, a 134.83% increase year-over-year.
- PMGC HOLDINGS INC. travel and entertainment expense for the quarter ending 2025-09-30 was $64.27K, a 868.40% increase year-over-year.
- PMGC HOLDINGS INC. travel and entertainment expense for fiscal 2025 was $160.38K, a 461.13% increase from fiscal 2024.
- PMGC HOLDINGS INC. travel and entertainment expense for fiscal 2024 was $28.58K, a 47.44% increase from fiscal 2023.
- PMGC HOLDINGS INC. travel and entertainment expense for fiscal 2023 was $19.39K, a 90.23% decline from fiscal 2022.
- PMGC HOLDINGS INC. travel and entertainment expense for fiscal 2022 was $198.44K.
| Period end | Travel and Entertainment Expense 3 month | Travel and Entertainment Expense 3 month as first filed | Travel and Entertainment Expense 6 month | Travel and Entertainment Expense 6 month as first filed | Travel and Entertainment Expense 9 month | Travel and Entertainment Expense 9 month as first filed | Travel and Entertainment Expense 12 month | Travel and Entertainment Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $63.44K 10-Q · filed 2026-08-14 | $171.78K 10-Q · filed 2026-08-14 | $212.47K derived: sum of 3 quarters · filed 2026-08-14 | $276.74K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $108.34K 10-Q · filed 2026-05-15 | $149.03K derived: sum of 2 quarters · filed 2026-05-15 | $213.31K derived: sum of 3 quarters · filed 2026-05-15 | $229.50K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $40.69K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $104.97K derived: sum of 2 quarters · filed 2026-03-30 | $121.16K derived: sum of 3 quarters · filed 2026-08-14 | $160.38K 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $64.27K 10-Q · filed 2025-11-14 | $80.46K derived: sum of 2 quarters · filed 2026-08-14 | $119.68K 10-Q · filed 2025-11-14 | $137.01K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $16.19K 10-Q · filed 2026-08-14 | $55.41K 10-Q · filed 2026-08-14 | $72.74K derived: sum of 3 quarters · filed 2026-08-14 | $79.38K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $39.22K 10-Q · filed 2026-05-15 | $56.55K derived: sum of 2 quarters · filed 2026-05-15 | $63.19K derived: sum of 3 quarters · filed 2026-05-15 | $67.80K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $17.33K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $23.96K derived: sum of 2 quarters · filed 2026-03-30 | $28.58K derived: sum of 3 quarters · filed 2026-03-30 | $28.58K 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $6.64K 10-Q · filed 2025-11-14 | $44.38K 10-Q · filed 2024-11-14 | $11.25K derived: sum of 2 quarters · filed 2025-11-14 | $11.25K 10-Q · filed 2025-11-14 | $160.61K 10-Q · filed 2024-11-14 | -$160.25K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $4.62K 10-Q · filed 2025-08-13 | $57.12K 10-Q · filed 2024-08-14 | $4.62K 10-Q · filed 2025-08-13 | $116.23K 10-Q · filed 2024-08-14 | -$166.89K derived: sum of 3 quarters · filed 2025-08-13 | -$101.06K derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $59.11K 10-Q · filed 2024-05-15 | -$171.51K derived: sum of 2 quarters · filed 2025-03-28 | -$105.68K derived: sum of 3 quarters · filed 2025-03-28 | $16.98K derived: sum of 4 quarters · filed 2025-03-28 | ||||
| 2023-12-31 | -$230.62K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$164.78K derived: sum of 2 quarters · filed 2025-03-28 | -$42.13K derived: sum of 3 quarters · filed 2025-03-28 | $19.39K 10-K · filed 2025-03-28 | $339.15K 10-K · filed 2024-03-29 | |||
| 2023-09-30 | $65.83K 10-Q · filed 2024-11-14 | $65.83M 10-Q · filed 2023-12-11 | $188.49K derived: sum of 2 quarters · filed 2024-11-14 | $250.00K 10-Q · filed 2024-11-14 | $250.00M 10-Q · filed 2023-12-11 | -$148.05M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $122.66K 10-Q · filed 2024-08-14 | $184.17K 10-Q · filed 2024-08-14 | -$148.11M derived: sum of 3 quarters · filed 2024-08-14 | -$92.22M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $61.52K 10-Q · filed 2024-05-15 | -$148.24M derived: sum of 2 quarters · filed 2024-05-15 | -$92.34M derived: sum of 3 quarters · filed 2024-05-15 | |||||
| 2022-12-31 | -$148.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$92.40M derived: sum of 2 quarters · filed 2024-03-29 | $198.44K 10-K · filed 2024-03-29 | |||||
| 2022-09-30 | $55.89M 10-Q · filed 2023-12-11 | $148.50M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |